Nom Action | Symbole Action | Marché | Type |
---|---|---|---|
Cyclerion Therapeutics Inc | CYCN | NASDAQ | Action ordinaire |
Ouverture | Plus Bas | Plus Haut | Prix de clôture | Clôture Veille |
---|---|---|---|---|
2,21 |
Actualités Recentes
Date | Heure | Source | Titre |
---|---|---|---|
14/6/2024 | 22:05 | EDGAR2 | Form 8-K - Current report |
07/5/2024 | 22:30 | EDGAR2 | Form 10-Q - Quarterly report [Sections 13 or 15(d)] |
26/1/2024 | 22:05 | EDGAR2 | Form 4 - Statement of changes in beneficial ownership of.. |
11/12/2023 | 23:09 | EDGAR2 | Form 3 - Initial statement of beneficial ownership of.. |
04/12/2023 | 23:09 | EDGAR2 | Form 8-K - Current report |
04/12/2023 | 14:00 | GLOBE | Cyclerion Appoints Regina Graul, Ph.D., as President |
01/12/2023 | 14:01 | EDGAR2 | Form 8-K - Current report |
01/12/2023 | 00:16 | GLOBE | Cyclerion Strengthens Board of Directors with Experienced.. |
24/11/2023 | 19:06 | EDGAR2 | Form 8-K - Current report |
13/11/2023 | 22:30 | EDGAR2 | Form 10-Q - Quarterly report [Sections 13 or 15(d)] |
23/10/2023 | 22:58 | EDGAR2 | Form 8-K - Current report |
31/7/2023 | 13:00 | GLOBE | Tisento Launches with $81 Million From Top-Tier Investor.. |
28/7/2023 | 22:48 | EDGAR2 | Form 10-Q - Quarterly report [Sections 13 or 15(d)] |
19/7/2023 | 23:27 | EDGAR2 | Form 8-K - Current report |
12/7/2023 | 22:12 | EDGAR2 | Form 8-K - Current report |